SC

Samayjanrao Chikate

Active Director Director DIN 08142292
DIN 08142292 First appointment May 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Samayjanrao Chikate

Data last updated:

Samayjanrao Chikate is a Director at Newgenic Healthcare Private Limited (since 2018). The company operates in Business Services.

DIN 08142292
Primary Designation Director
Industry Business Services
First Appointment 24 May 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Newgenic Healthcare Private Limited U74999TG2018PTC124732
Director24 May 20182018Active

Board colleagues of Samayjanrao Chikate

NameDINCompanyDesignation
Purneema Nilkanth Kamble07512753Newgenic Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Newgenic Healthcare Private Limited
Premium access

Shareholding and investment profile for Samayjanrao Chikate

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Samayjanrao Chikate

Samayjanrao Chikate currently holds 1 directorship: Newgenic Healthcare Private Limited (Director, since 24 May 2018).

Samayjanrao Chikate was first appointed on 24 May 2018 as Director at Newgenic Healthcare Private Limited.

The current boards of Samayjanrao Chikate's companies include Purneema Nilkanth Kamble (Newgenic Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available